{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:13:44Z","timestamp":1791807224998,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"am","delay-in-days":306,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006458","name":"Children's Hospital of Philadelphia","doi-asserted-by":"publisher","award":["LB805"],"award-info":[{"award-number":["LB805"]}],"id":[{"id":"10.13039\/100006458","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006518","name":"University of Nebraska Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01NS128336"],"award-info":[{"award-number":["1R01NS128336"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01NS116037"],"award-info":[{"award-number":["1R01NS116037"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jconrel.2025.113902","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T19:15:04Z","timestamp":1748546104000},"page":"113902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["COG133 peptide-conjugated lipid nanoparticles sensitize medulloblastoma to radiation therapy in mice"],"prefix":"10.1016","volume":"384","author":[{"given":"Aditya","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohan","family":"Mahto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Oberley Deegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald W.","family":"Coulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram I.","family":"Mahato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113902_bb0005","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.tips.2017.09.002","article-title":"Challenges and recent advances in medulloblastoma therapy","volume":"38","author":"Kumar","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2025.113902_bb0010","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrc2419","article-title":"Exploring the role of cancer stem cells in radioresistance","volume":"8","author":"Baumann","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.113902_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep15666","article-title":"PLK1 blockade enhances therapeutic effects of radiation by inducing cell cycle arrest at the mitotic phase","volume":"5","author":"Inoue","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.113902_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-12-80","article-title":"Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells","volume":"12","author":"Harris","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jconrel.2025.113902_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/leu.2014.222","article-title":"Discovery and development of the polo-like kinase inhibitor volasertib in cancer therapy","volume":"29","author":"Gjertsen","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2025.113902_bb0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/stem.318","article-title":"Radiation resistance of cancer stem cells: the 4 r\u2019s of radiobiology revisited","volume":"28","author":"Pajonk","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.jconrel.2025.113902_bb0035","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2004.03.005","article-title":"Role of cell cycle in mediating sensitivity to radiotherapy","volume":"59","author":"Pawlik","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jconrel.2025.113902_bb0040","unstructured":"https:\/\/oncoheroes.com\/pipeline-volasertib, Oncoheroes, 2024."},{"key":"10.1016\/j.jconrel.2025.113902_bb0045","unstructured":"https:\/\/www.clinicaltrialsarena.com\/news\/notable-labs-launch-trial-with-failed-volasertib\/, Notable Labs, 2024."},{"key":"10.1016\/j.jconrel.2025.113902_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw2672","article-title":"Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma","volume":"12","author":"Wang","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.113902_bb0055","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-06-3948","article-title":"Tumor paint: a chlorotoxin: Cy5. 5 bioconjugate for intraoperative visualization of cancer foci","volume":"67","author":"Veiseh","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113902_bb0060","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.M205662200","article-title":"Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2","volume":"278","author":"Deshane","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2025.113902_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120272","article-title":"Exploring the therapeutic potential of the bioinspired reconstituted high density lipoprotein nanostructures","volume":"596","author":"Gupta","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113902_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010038","article-title":"ApoE-targeting increases the transfer of solid lipid nanoparticles with donepezil cargo across a culture model of the blood-brain barrier","volume":"13","author":"Topal","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113902_bb0075","doi-asserted-by":"crossref","first-page":"2173333","DOI":"10.1080\/10717544.2023.2173333","article-title":"Development of an apolipoprotein E mimetic peptide\u2013lipid conjugate for efficient brain delivery of liposomes","volume":"30","author":"Kato","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.113902_bb0080","article-title":"Phase II trial of blood\u2013brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma","volume":"6","author":"Dmello","year":"2024","journal-title":"Neuro Oncol. Adv."},{"key":"10.1016\/j.jconrel.2025.113902_bb0085","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1021\/acsnano.8b05265","article-title":"Apolipoprotein E peptide-directed chimeric Polymersomes mediate an ultrahigh-efficiency targeted protein therapy for glioblastoma","volume":"12","author":"Jiang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113902_bb0090","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jconrel.2020.04.053","article-title":"ApoE mimetic peptide targeted nanoparticles carrying a BRD4 inhibitor for treating Medulloblastoma in mice","volume":"323","author":"Wang","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113902_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-31926-9","article-title":"Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment","volume":"13","author":"Reda","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113902_bb0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tranon.2016.10.003","article-title":"PLK1, a potential target for cancer therapy","volume":"10","author":"Liu","year":"2017","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jconrel.2025.113902_bb0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.genet.40.051206.105231","article-title":"Surviving the breakup: the DNA damage checkpoint","volume":"40","author":"Harrison","year":"2006","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.jconrel.2025.113902_bb0110","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1172\/JCI122533","article-title":"PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas","volume":"128","author":"Ren","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.113902_bb0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molcel.2016.09.016","article-title":"Polo-like kinase-1 regulates Myc stabilization and activates a feedforward circuit promoting tumor cell survival","volume":"64","author":"Xiao","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2025.113902_bb0120","series-title":"Neuroimmune Pharmacology and Therapeutics","first-page":"585","article-title":"Pharmacogenomics of neurodegenerative diseases: Roles in personalized medicines","author":"Gupta","year":"2024"},{"key":"10.1016\/j.jconrel.2025.113902_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121138","article-title":"Polymeric nanomedicine for overcoming resistance mechanisms in hedgehog and Myc-amplified medulloblastoma","volume":"278","author":"Kumar","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113902_bb0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2022.12.055","article-title":"Targeting BRD4 and PI3K signaling pathways for the treatment of medulloblastoma","volume":"354","author":"Sethi","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113902_bb0135","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm8011","article-title":"Blood-brain barrier\u2013penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy","volume":"8","author":"Zou","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.113902_bb0140","doi-asserted-by":"crossref","first-page":"2000416","DOI":"10.1002\/adma.202000416","article-title":"Single siRNA nanocapsules for effective siRNA brain delivery and glioblastoma treatment","volume":"32","author":"Zou","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113902_bb0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11060-023-04319-1","article-title":"Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells","volume":"163","author":"Valinciute","year":"2023","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.jconrel.2025.113902_bb0150","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s40262-017-0566-9","article-title":"Population pharmacokinetics of volasertib administered in patients with acute myeloid leukaemia as a single agent or in combination with cytarabine","volume":"57","author":"Solans","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2025.113902_bb0155","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1158\/1078-0432.CCR-08-2445","article-title":"BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity","volume":"15","author":"Rudolph","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113902_bb0160","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ijrobp.2006.06.043","article-title":"Effects of fractionated radiation on the brain vasculature in a murine model: blood\u2013brain barrier permeability, astrocyte proliferation, and ultrastructural changes","volume":"66","author":"Yuan","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jconrel.2025.113902_bb0165","first-page":"44","article-title":"Blood-brain barrier permeability following conventional photon radiotherapy\u2013a systematic review and meta-analysis of clinical and preclinical studies","volume":"35","author":"Od\u00e9","year":"2022","journal-title":"Clin. Transl. Radiat. Oncol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592500522X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592500522X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:47:56Z","timestamp":1779511676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592500522X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":33,"alternative-id":["S016836592500522X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113902","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COG133 peptide-conjugated lipid nanoparticles sensitize medulloblastoma to radiation therapy in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113902"}}